Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio…
ISLE 2025 to Open on March 7: Global Innovation & Production Hub of LED Display & Integrated System
SHENZHEN, China, Feb. 10, 2025 /PRNewswire/ -- ISLE 2025, Asia's biggest exhibition…
CIFF Guangzhou 2025 Preview: A Showcase of Innovation and Sustainability
GUANGZHOU, China, Feb. 10, 2025 /PRNewswire/ -- The second phase of the 55th…
Design Milan: An Innovation Festival Hosted by IDeA World College
BENGALURU, India, Feb. 5, 2025 /PRNewswire/ -- India's most awaited cultural fest, Design…
Colossyan Leads AI Innovation with Strong 2024 Performance
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Colossyan, a leading text-to-speech AI video…
Colossyan Achieves 155% Revenue Growth, Leading AI Video Innovation
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Colossyan, a leading text-to-speech AI video…
Circuits Integrated Hellas Selected as Laureate for Paris Space Week 2025 Innovation Challenge
ATHENS, Greece, Feb. 02, 2025 (GLOBE NEWSWIRE) -- Circuits Integrated Hellas (CIH),…
VJ Biosciences Debuts at 5th Annual Summit of Biologics Conferences with a Bold Vision for Biopharmaceutical Innovation
BANGALORE, India, Feb. 3, 2025 /PRNewswire/ -- New York-based VJ Group announced…
Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024
Ad hoc announcement pursuant to Art. 53 LRFull yearNet sales grew +12%…
Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia
January 30, 2025 05:00 ET | Source: Comanche Biopharma ILAP aims to…